PIM
Platinum Investment Management Portfolio holdings
AUM
$1.5B
This Quarter Return
+15.66%
1 Year Return
+16.62%
3 Year Return
+100.57%
5 Year Return
+187.54%
10 Year Return
+422.09%
AUM
$5.05B
AUM Growth
+$5.05B
(+13%)
Cap. Flow
+$26.6M
Cap. Flow
% of AUM
0.53%
Top 10 Holdings %
Top 10 Hldgs %
56.49%
Holding
107
New
8
Increased
24
Reduced
25
Closed
9
Top Buys
| 1 |
Trip.com Group
TCOM
|
$79.4M |
| 2 |
WUBA
58.COM INC
WUBA
|
$49.8M |
| 3 |
Gilead Sciences
GILD
|
$47.8M |
| 4 |
Schlumberger
SLB
|
$43.4M |
| 5 |
SAVE
Spirit Airlines, Inc.
SAVE
|
$33.4M |
Top Sells
| 1 |
Autohome
ATHM
|
$105M |
| 2 |
Weibo
WB
|
$77.8M |
| 3 |
Intel
INTC
|
$53.1M |
| 4 |
SINA
Sina Corp
SINA
|
$46.2M |
| 5 |
Alibaba
BABA
|
$40M |
Sector Composition
| 1 | Communication Services | 21.45% |
| 2 | Technology | 21.15% |
| 3 | Consumer Discretionary | 18.79% |
| 4 | Industrials | 14.36% |
| 5 | Energy | 7.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Johnson & Johnson
JNJ
$427B
| $3.5M | 0.07% | 24,000 +7,339 | +44% | +$1.07M |
|
52
Topgolf Callaway Brands
MODG
$1.76B
| $3.18M | 0.06% | 149,932 -125,028 | -45% | -$2.65M |
|
53
Dianthus Therapeutics
DNTH
$759M
| $3.15M | 0.06% | 208,038 -54,416 | -21% | -$825K |
|
|
NSTG
54
DELISTED
NanoString Technologies, Inc.
NSTG
| $3.06M | 0.06% | 110,125 | – | – |
|
55
Agios Pharmaceuticals
AGIO
$2.19B
| $2.93M | 0.06% | 61,434 +10,351 | +20% | +$494K |
|
56
Lam Research
LRCX
$127B
| $2.9M | 0.06% | 9,931 | – | – |
|
57
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $2.89M | 0.06% | 160,263 -7,974 | -5% | -$144K |
|
|
AERI
58
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $2.75M | 0.05% | 113,842 +11,193 | +11% | +$271K |
|
|
XLRN
59
DELISTED
Acceleron Pharma Inc.
XLRN
| $2.73M | 0.05% | 51,489 | – | – |
|
60
Revvity
RVTY
$10.5B
| $2.66M | 0.05% | 27,347 | – | – |
|
61
Merus
MRUS
$4.98B
| $2.4M | 0.05% | 170,112 +31,012 | +22% | +$437K |
|
62
Fulcrum Therapeutics
FULC
$351M
| $2.31M | 0.05% | 138,767 +63,767 | +85% | +$1.06M |
|
63
Esperion Therapeutics
ESPR
$448M
| $2.29M | 0.05% | +38,454 | New | +$2.29M |
|
64
Prothena Corp
PRTA
$441M
| $2.23M | 0.04% | 140,943 -49,048 | -26% | -$776K |
|
65
Apple
AAPL
$3.45T
| $2.07M | 0.04% | 7,048 -632 | -8% | -$186K |
|
66
Alnylam Pharmaceuticals
ALNY
$58.5B
| $1.81M | 0.04% | 15,741 -6,914 | -31% | -$796K |
|
67
PayPal
PYPL
$67.1B
| $1.78M | 0.04% | 16,437 | – | – |
|
|
DERM
68
DELISTED
Dermira, Inc.
DERM
| $1.76M | 0.03% | 116,325 | – | – |
|
69
Cisco
CSCO
$274B
| $1.71M | 0.03% | 35,700 | – | – |
|
70
LivaNova
LIVN
$3.08B
| $1.71M | 0.03% | 22,698 | – | – |
|
71
Sangamo Therapeutics
SGMO
$157M
| $1.64M | 0.03% | 196,265 +27,680 | +16% | +$232K |
|
72
Alector
ALEC
$238M
| $1.6M | 0.03% | 92,933 | – | – |
|
73
Oracle
ORCL
$635B
| $1.56M | 0.03% | 29,418 | – | – |
|
|
BPMC
74
DELISTED
Blueprint Medicines
BPMC
| $1.53M | 0.03% | 19,094 +6,348 | +50% | +$509K |
|
75
Carnival Corp
CCL
$43.2B
| $1.49M | 0.03% | 29,260 | – | – |
|